Investing
AstraZeneca shares fall 3.6% to 7-1/2 week low
© Reuters. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
LONDON (Reuters) – Shares in London-listed drugmaker AstraZeneca (NASDAQ:) declined as much as 3.6% on Monday, falling to their lowest since July 19.
Traders attributed the move to a report in the Mail on Sunday newspaper saying the drugmaker’sChief Executive Pascal Soriot had said privately to friends and advisers that he may leave the company as soon as next year.
Reuters could not independently verify the information.
AstraZeneca declined to comment on the report.
Read the full article here
-
Passive Income7 days ago
How to Create a Routine That Balances Rest and Business Success
-
Investing7 days ago
This All-Access Pass to Learning Is Now $20 for Black Friday
-
Side Hustles5 days ago
A Macy’s Employee Made Accounting Errors Worth $132 Million
-
Investing4 days ago
Factbox-How Trump can overhaul US financial regulators when he takes office By Reuters
-
Passive Income4 days ago
5 Ways AI Can Accelerate Your Entrepreneurial Journey
-
Side Hustles3 days ago
Closing Your Business? Do It Before the New Year to Save Money
-
Make Money2 days ago
20 Cities Experiencing a Surge in New Business Applications
-
Side Hustles7 days ago
Gift the Power of Language Learning with This Limited-Time Price on Babbel